Direct Inhibition of STAT Signaling by Platinum Drugs Contributes to Their Anti-Cancer Activity

Oncotarget - United States
doi 10.18632/oncotarget.17661
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Mechanistic and Structural Basis for Inhibition of Copper Trafficking by Platinum Anticancer Drugs

English

Corrigendum: Inhibition of JAK-STAT Signaling Stimulates Adult Satellite Cell Function

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

A Tumor Suppressor Activity of Drosophila Polycomb Genes Mediated by JAK-STAT Signaling

Nature Genetics
Genetics
2009English

Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity Against Breast Cancer Models Resistant to Anti-Her2 Drugs

PLoS ONE
Multidisciplinary
2015English

Curcumin Derivatives: Molecular Basis of Their Anti-Cancer Activity

Biochemical Pharmacology
BiochemistryPharmacology
2009English

Targeting of Radioactive Platinum-Bisphosphonate Anticancer Drugs to Bone of High Metabolic Activity

Scientific Reports
Multidisciplinary
2020English

958 Pharmacological Inhibition of JAK/STAT Signaling by Tofacitinib Prevents Organ Fibrosis: Novel Therapy for Scleroderma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Inhibition of TRPC6 Channel Activity Contributes to the Antihypertrophic Effects of Natriuretic Peptides-Guanylyl Cyclase-A Signaling in the Heart

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2010English

COX-2 Inhibition, Apoptosis, and Chemoprevention by Nonsteroidal Anti-Inflammatory Drugs.

Current Medicinal Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular MedicinePharmacology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy